Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2004 | A mutation in human topoisomerase II whose expression is lethal in DNA repair-deficient yeast cells. | Walker, JV; Nitiss, KC; Jensen, LH; Mayne, C; Hu, T; Jensen, PB; Sehested, M; Hsieh, T; Nitiss, JL | J. Biol. Chem. 279, 25947-25954. | | | |
1998 | Analysis of a core domain in Drosophila DNA topoisomerase II: Targeting of an anti-tumor agent ICRF-159. | Chang, S; Hu, T; Hsieh, TS | J. Biol. Chem. 273, 19822-19828. | | | |
2002 | ATPase domain of eucaryotic DNA topoisomerase II: Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization. | Hu, T; Sage, H; Hsieh, TS | J. Biol. Chem. 277, 5944-5951. | | | |
1998 | Identifying Lys359 as a critical residue for the ATP-dependent reactions of Drosophila DNA topoisomerase II. | Hu, T; Chang, S; Hsieh, TS | J. Biol. Chem. 273, 9586-9592. | | | |
1999 | The hydrophilic, protease-sensitive terminal domains of eucaryotic DNA topoisomerases have essential intracellular functions. | Shaiu, WL; Hu, T; Hsieh, TS. | | | | |